Maqui and Omega 3: effects on lipid profile,  oxidative stress levels and psycho-physical items in  human subjects by Cavezzi, Attilio et al.
ORIGINAL ARTICLE
Discovery Phytomedicine 2017, Volume 4, Number 2: 26-30
26 Discovery Phytomedicine 2017; 4(2): 26-30. doi: 10.15562/phytomedicine.2017.42 www.phytomedicine.ejournals.ca
CrossMark
ABSTRACT
Aims: to assess short-term efficacy of supplementation with Maqui 
(Aristotelia Chilensis (Mol.Stuntz)), a polyphenol with antioxidant 
power, and EPA/DHA concerning metabolism, oxidative stress and 
mental/physical state.
Patients and Methods: a pilot prospective observational clinical/
laboratory study was performed on 17 apparently healthy subjects 
(8 males and 9 females, mean age 47 years). All subjects received for two 
months: a) Maqui 600 mg per day and b) 360 mg of EPA and 240 mg 
of DHA (salmon oil) daily. At day 0 and day 60 all subjects underwent 
nine laboratory tests related to inflammation, metabolism (lipid profile 
mainly) and oxidative stress parameters. Pre-post treatment weight 
and BMI was calculated. A few physical and mental parameters were 
assessed by means of Short-Form 12 questionnaire. Statistical analysis 
was applied to the resulting data through Wilcoxon test and t-paired test. 
Results: laboratory results before and after Maqui + EPA/DHA 
supplementation were respectively (mean and p-value for the 
comparison): total cholesterol 228.8/199.8 mg/dl, p=0.23; low density 
lipoproteins 127.4/122.1 mg/dl, p=0.13; high density lipoproteins 
59.1/57.6 mg/dl, p=0.25; reactive C protein 0.18/0.09 mg/dl, p=0.32; 
triglycerides 106.1/91.1 mg/dl p=0.09, glycemia 92.9/92.8 mg/dl 
p= 0.92; total free radicals 338.0/303.6 U.Carr., p=0.002; serum anti-
oxidant capacity 2075/2190 umol/l, p=0.04; oxidized lipoproteins 
641.8/553.1 uEq/l, p=0.10. SF-12 physical and mental items (mean 
values and SD) were 51.2 (+/- 6.2) and 41.2 (+/- 3.3) at day 0 and 
54.6 (+/- 11.6) and 47.2 (+/- 9.7) at day 60 respectively. One case of 
transient constipation was recorded.
Conclusions: daily supplementation with Maqui 600 mg + Omega 3 
fatty acids (EPA 360 mg + DHA 240 mg) in apparently healthy middle-
aged subjects resulted in a statistically significant improvement of 
oxidative stress parameters. An overall (non statistically significant) 
improvement of dysmetabolism biomarkers was achieved. 
Psychological and physical parameters have mildly improved.
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INTRODUCTION 
The natural process of reactive oxygen species (ROS) 
production may derange and result in an  excessive 
oxidative stress. In the last  thirty-forty years liter-
ature data have shown how an imbalance between 
the ROS generating processes and the antioxidant 
defence mechanisms may be of relevance in the 
genesis of multiple diseases, such as cardiovas-
cular diseases, cancer, atherosclerosis, diabetes, 
neurodegenerative diseases, etc.1 ROS are contin-
uously eliminated by several  intracellular and 
extracellular antioxidant systems, but an excessive 
oxidative stress with associated increased ROS 
production may induce alterations in  cellular 
macromolecules, primarily DNA, lipids and 
proteins. ROS  accumulation results in a series  of 
possible biochemical lesions, with free radicals 
triggering multiple mutations in the natural cellu-
lar bio-architecture; ultimately an alteration of 
cellular apoptosis mechanisms and the  generation 
of low grade chronic cellular inflammation (at the 
basis of the so called “inflammaging”) has been 
attributed to oxidative stress as well.2 Diverse 
potential fields of interest of natural antioxidants, 
such as polyphenols, have been highlighted in the 
prevention or control of different diseases linked to 
the negative impact of free radicals. Food supple-
ments containing polyphenols, may play a role in a 
few metabolism alterations, such as dyslipidemias,3 
type II diabetes,4 amyloid-rich  neurodegeneration.5 
More specifically anti-oxidants may exert a posi-
tive effect on a few parameters of oxidative stress 
and free-radical production, hence they may play 
a role in the control of cardiovascular degenera-
tive processes,6 of inflammaging degeneration and 
in neurodegenerative diseases.7 In the latest years 
maqui (Aristotelia Chilensis (Mol.Stuntz), an 
anthocianin (delphinidin mainly)-rich berry from 
Chilean Patagonia, has been recognised as one of 
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the most powerful antioxidant natural principle in 
nature.8 According to several scientific publications 
Maqui showed its adjuvant valuable role in several 
dysmetabolism-related diseases. More specifically 
maqui administration proved to reduce biomark-
ers of oxidative stress8-10 and to improve lipid and 
glycemia metabolism.8,11,12 
Within the metabolism alterations, triglycerides 
represent one of the key-factors in the athero-
genic process, and more generally of metabolic 
syndrome. Omega 3 fatty acids have shown a 
clear positive influence on metabolism and cellu-
lar  inflammation3 through the their two classical 
components: EPA and DHA. Supplementation 
with omega 3, which is mostly based on fish oil 
components, has proved to achieve a decrease of 
triglycerides level as well.14 
This pilot study has been performed with the aim 
to assess short-term efficacy of maqui + EPA/DHA 
supplements on metabolism and oxidative stress 
of middle-aged apparently healthy subjects, with 
low-to-mild metabolic dysfunctions. In order to 
elicit a possible positive effect of the dietary supple-
ments as to above, the following main parameters 
were investigated: a) biomarkers of oxidative stress 
and metabolism alterations through laboratory 
blood testing, b) mental and physical state assess-
ment through a validated score system, c) anthro-
pomorphic basic parameters.
PATIENTS AND METHODS
A pilot prospective observational clinical and labo-
ratory study was performed on 17 middle aged 
subjects (8 males and 9 females, mean age 47 years, 
mean BMI 23.9). Inclusion criteria were: subjects in 
the age 30-55 years, body mass index (BMI) up to 35. 
Exclusion criteria were: active cancer, cardiac/renal/
liver insufficiency, ongoing therapy with steroids, 
lipid targeting drugs, anti- inflammatory drugs or 
with hormones, antioxidants, multivitamins. 
All subjects signed an informed consent and 
the study was performed in accordance with the 
 principles of Helsinki Declaration.
The participants of this investigated single group 
were administered for two months with: a) maqui 
(Aristotelia Chilensis (Mol.Stuntz), maqui, estratto 
secco titolato KOS srl) two tablets per day, for a 
total of 600 mg of dry extract 1:10 of maqui berry 
per day (a dose which is coherent with other litera-
ture data,9 b) two pearls per day of salmon oil (Olio 
di pesce, KOS srl) (2000 mg daily) corresponding to 
360 mg of EPA and 240 mg of DHA per day. 
At day 0 all subjects underwent blood exam-
ination and the following nine laboratory tests 
were performed: total cholesterol, low density 
lipoproteins (LDL), high density lipoproteins (HDL), 
reactive C protein (RCP), triglycerides, glycemia, 
total free radicals, serum anti-oxidant capacity 
(SAC), oxidized lipoproteins. Blood samples were 
collected by venipuncture with Vacutainer system; 
all the metabolites were measured on automatic 
instrumentation (Architect, Abbott Laboratories). 
The examined parameters were assessed in plasma 
fluorure EDTA (glycemia) and on serum (the 
remaining tests). The following methods were used: 
esokinase-based spectrophotometry for glycemia; 
enzymatic method for lipid profile (i.e. total choles-
terol, HDL, LDL, triglycerides); immunoturbidi-
metry for RCP; photometry for free radicals, SAC 
and oxidized lipoproteins. After 60 days of supple-
mentation all subjects repeated the same blood 
tests related to cellular inflammation / lipid profile / 
oxidative stress parameters. 
Pre-post/treatment weight and BMI was calcu-
lated as well, while blood pressure was measured at 
day 0, day 30 and day 60. Finally patient-reported 
outcomes related to a few physical and psycho-
logical parameters concerning their daily life were 
assessed by means of short-form 12 questionnaire 
(SF-12) at day 0 and day 60. 
Any adverse event was recorded throughout the 
period of the study. 
No additional treatment was allowed and a 
stable life regimen was recommended to all subjects 
who received a written information on this specific 
issue. 
All data were collected and analysed for statis-
tics by one of the authors (G.M.); statistical analysis 
was applied to the resulting data by means of PSPP 
and GraphPad Prism softwares, and p-value was 
calculated for main variables through t-paired test 
and through Wilcoxon test. A 0.05 cut-off p-value 
was considered as statistically significant for all the 
investigated variables.
RESULTS
An overall improvement of most laboratory param-
eters was recorded at two months follow-up with 
a statistically significant difference for oxidative 
stress biomarkers values. 
Pre-post Maqui + EPA/DHA  supplementation 
laboratory results were respectively as follows 
(mean and p-value for the pre-post/treatment 
comparison): total cholesterol 228.8/199.8 mg/dl, 
p=0.23; LDL 127.4/122.1 mg/dl, p=0.13; HDL 
59.1/57.6  mg/dl, p=0.25; triglycerides 106.1/91.1 
mg/dl p=0.09; oxidized lipoproteins 641.8/ 
553.1 uEq/l, p=0.10; RCP 0.18/0.09  mg/dl, 
p=0.32; glycemia 92.9/92.8  mg/dl p=0.92; total 
free radicals 338.0/303.6 U.Carr., p=0.002; SAC 
28 Discovery Phytomedicine 2017; 4(2): 26-30. doi: 10.15562/phytomedicine.2017.42 www.phytomedicine.ejournals.ca
Maqui and Omega 3: ... Cavezzi A., et al.
2075/2190 umol/l, p=0.04. Mean weight at day 0 
and day 60 was 68.9 Kg and 68.0 Kg respectively 
(p=0.19). Mean values of blood pressure were in 
the range of normality for all the recruited subjects: 
the range of systolic/diastolic pressure figures was 
130-150  mmHg and 70-85  mmHg respectively) 
throughout the controls at T0, T30 and T60. 
Figure 1 shows the graphic representation of the 
main laboratory variables analysed and the relative 
pre-post-supplementation figures.
Mean and standard deviation figures for SF-12 
at day 0 for physical and mental items were 51.2 
(+/- 6.2) and 41.2 (+/- 3,3) respectively; at day 60 
physical and mental figures were 54.6 (+/- 11.6) and 
47.2 (+/- 9.7) respectively (Figure 3).
No significant adverse event was reported by the 
subjects. One case of constipation was recorded and 
the patient halved the maqui dose to continue the 
study.
There were no drop-off subjects, hence all data 
from the 17 included subjects were available for the 
assessment of the final results.
DISCUSSION
The involvement of oxidative stress as common 
factor in the pathogenesis of various chronic degen-
erative diseases has been highlighted in literature.1 
A balance between the production of oxidants/ROS 
and defensive antioxidants may be essential to a 
healthy aging. The oxidative stress may be defined 
as “a state where oxidative force exceeds the anti-
oxidant systems due to loss of the balance between 
them”.15
A growing number of studies suggest an 
 association between a polyphenol-rich diet and a 
positive impact on cardiac16 and cerebral degener-
ative diseases.7 More generally a positive influence 
of a few specific anti-oxidant phytochemicals on 
longevity has been highlighted in recent literature.17 
The beneficial role of maqui on dysmetabolism and 
against free radicals has been confirmed in differ-
ent studies,8,9 where oxidative stress biomarkers, 
as well as glycid and lipid metabolism parameters 
improved.
Omega 3 fatty acids have been shown to improve 
lipid profile and reduce chronic-low-grade cellular 
inflammation.13,14,18 
The combination of these two active ingredients 
was recognised as beneficial in longevity medi-
cine and seems to play a role in the control of the 
 inflammaging process.19 The present study aimed 
to assess the short-term efficacy of the admin-
istration of maqui tablets (600 mg per day) and 
omega 3 pearls (corresponding to 360 mg of EPA 
and 240  mg of DHA per day) through the moni-
toring of a few parameters related to metabolism, 
oxidative stress and psychological/physical state in 
middle-aged subjects, having apparently no rele-
vant diseases.
The results of this preliminary study confirm 
the statistically significant improvement of the 
two main biomarkers of oxidative stress (total free 
radicals and SAC), which is mostly attributable to 
the delphinidins of maqui. In fact anthocyanins 
in maqui berry are mostly represented by delphi-
nidins, which were shown to exhibit a significant 
bioavailability and efficacy on different targets in the 
so called “healthy aging” process.8,9,20 Conversely no 
other statistically significant difference was found 
in the lipid profile after the combined administra-
tion of the two food supplements.
In fact triglycerides, LDL, total cholesterol and 
oxidized LDL presented an overall improvement in 
the vast majority of the subjects, but the difference 
was not statistically significant within the investi-
gated cohort.
Interestingly, subjects with altered lipid profile 
showed better results, whereas no specific changes 
were highlighted in the glycemia (which basically 
Figure 1 graphic representation of main laboratory parameters
Figure 2 Short-Form 12 data
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resulted in the range of normality  pre-post-dietary 
supplements administration), HDL and RCP 
figures. It is possible to speculate that the inves-
tigated nutraceuticals could have shown a more 
pronounced action in patients with pathologic lipid 
profile, type II diabetes and in older age. 
A larger group of subjects would have been needed 
to validate these preliminary outcomes, possi-
bly through a comparison with a  placebo-group. 
Higher doses of maqui and especially of omega 3 
could have been used, eventually aiming at a more 
intense anti-oxidant and anti-inflammaging effect. 
Scapagnini and coll.9 showed similar results on 
oxidative stress biomarkers, whereas little changes 
in the lipid profile were achieved in their random-
ized controlled study as well.
We acknowledge that SF-12 is a very generic ques-
tionnaire, based on a scoring system which responds 
more to life style modifications than to nutrition/
nutraceutical influence on the daily mental and phys-
ical changes. Additionally the placebo-effect on the 
achieved improvement of the SF-12 questionnaire 
cannot be excluded. Somehow supplementation 
with maqui dry extract under the form of tablets, 
in combination with omega 3 pearls, has slightly 
improved the overall SF-12 scores. Some previously 
reported positive influence of maqui and delphini-
dins on AMP-kinase19,21 may corroborate the positive 
influence especially on the physical items changes.
Of interest, also omega 3 fatty acids have shown 
a positive influence on depressive mood,22 which 
may partially explain the relatively higher scoring 
in the mental items after the two months of supple-
mentation with fish oil. 
No relevant changes were noted in the weight and 
BMI figures at the end of the study, as well as blood 
pressure remained basically stable during the study 
duration in the investigated subjects. No relevant 
side effect was reported by the investigated subjects, 
though no specific test was performed to assess any 
change of liver/renal function. However literature 
data do not report any specific safety issue for the 
two phytonutrients administered in this study. 
The two main limitations of this study are the 
limited number of the investigated individuals and 
the lack of a control group, which may jeopardise 
the final results. Anyway this trial was intended as a 
pilot and preliminary investigation on the possible 
positive properties of maqui and of omega 3 fatty 
acids in subjects with limited metabolic alterations 
and oxidative stress. Our pilot study includes results 
which are linked to both nutrients, hence it is not 
possible to extrapolate the effects of each substance. 
Further studies are definitely needed to possibly 
confirm the data of our observational study on a 
small group of patients.
CONCLUSIONS
Daily supplementation with maqui 600 mg + omega 
3 fatty acids (EPA 360 mg + DHA 240 mg) in middle-
aged subjects, with mild metabolic  alterations and 
oxidative stress level, resulted in a statistically signifi-
cant reduction of free radicals and in an improvement 
of the anti-oxidant defence mechanisms. An overall 
(non statistically significant) improvement of dysme-
tabolism biomarkers was achieved as well. A mild 
improvement of psychological and physical parame-
ters has been recorded in the investigated cohort of 
subjects. No relevant side effects were reported and 
no  significant alteration of blood pressure or of body 
weight was recorded during the study. 
A larger trial, eventually with higher doses and 
anyway with a control group, is to be considered to 
possibly corroborate these preliminary results.
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